For a more detailed look at how the half-life shapes your week-by-week protocol, see the retatrutide dosing guide half-life section
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate
The prescription of psychedelic therapies in Australia and New Zealand: a brief survey of psychiatrists
Glucagon-like peptide-1 (GLP-1) receptor analogs are drugs that mimic fullness hormone GLP-1 and have been shown to reduce appetite, slow digestion, help stabilize blood sugar levels and impact metabolism
weight, circumferences), and BC using tools such as bioelectrical impedance vector analysis (BIVA), nutritional tissue ultrasound (to assess subcutaneous fat and muscle tissue), and handgrip strength testing
As semaglutide access continues to evolve, FDA-recognized options in 2026 reflect a broader trend toward individualized weight management strategies supported by medical governance rather than one-size-fits-all solutions